Effects of diltiazem on in vitro cardiovascular actions of crude venom obtained from Okinawan box-jellyfish (Habu-kurage), Chiropsalmus quadrigatus

Anaesthesia and Intensive Care

Volumn 30, Issue 5, 2002, Pages 570-577

  Sakanashi, M ^a   Matsuzaki, T ^a   Nakasone, J ^a   Koyama, T ^a   Kukita, I ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Venom: Habu kurage, Chiropsalmus quadrigatus, aorta, atrium, calcium, contraction, diltiazem

Indexed keywords

CALCIUM; DILTIAZEM; JELLYFISH VENOM; PHENTOLAMINE; UNCLASSIFIED DRUG; VENOM;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG EFFECT; HEART ATRIUM CONTRACTION; HEART RATE VARIABILITY; HEATING; IN VITRO STUDY; ISOLATED HEART; JELLYFISH; MALE; NONHUMAN; RAT; REPRODUCIBILITY; SMOOTH MUSCLE CONTRACTION; TACHYPHYLAXIS; THERMODYNAMICS; VASCULAR RING;

EID: 0036796790     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0203000504     Document Type: Article

References (22)

1. Cleland JB, Southcott RV. Injuries to man from marine invertebrates. In: National Health and Medical Research Council Special Report Series, Commonwealth of Australia, Canberra 1965; No. 12:12-175.
2. Barnes JH. Studies on three venomous cubomedusae. In: Rees WJ, eds. The Cnidaria and Their Evolution. Academic Press, New York 1966; 307-311.
3. Burnett JW, Currie B, Fenner PJ, Williamson JA. Cubozoans ("box-jellyfish"). In: Williamson JA, Fenner PJ, Burnett JW, Rifkin J, eds. Venomous and Poisonous Marine Animals. UNSW Press, Sydney 1996; 236-283.
4. Freeman SE, Turner RJ. A pharmacological study of the toxin in a Cnidarian, Chironex fleckeri Southcott. Br J Pharmac 1969; 35:510-520.
5. Keen TEB, Crone HD. The hemolytic properties of extracts of tentacles from the cnidarian Chironex fleckeri. Toxicon 1969; 7:55-63.
6. Burnett JW. The case for the use of verapamil in alarming Chironex stings. Anaesth Intensive Care 1998; 26:461-464.
7. Bloom DA, Burnett JW, Hebel JR, Alderslade P. Effects of verapamil and CSL antivenom on Chironex fleckeri (Box-jellyfish) induced mortality. Toxicon 1999; 37:1621-1626.
8. Nakamoto M, Uezato H. Stings of box-jellyfish and sea anemones. Jpn J Clin Dermatol 1998; 52 (SuppI 5):29-33 (in Japanese).
9. Wiltshire CJ, Sutherland SK, Fenner PJ, Young AR. Optimization and preliminary characterization of venom isolated from 3 medically important jellyfish: the box (Chironex fleckeri), Irukandji (Carukia barnesi), and blubber (Catostylus mosaicus) jellyfish. Wilderness Environ Med 2000; 11:241-250.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
11. Mustafa MR, White E, Hongo K, Othman I, Orchard CH. The mechanism underlying the cardiotoxic effect of the toxin from the jellyfish Chironex fleckeri. Toxicol Appl Pharmac 1995; 133:196-206.
12. Edwards L, Luo E, Hall R, Gonzalez RR Jr, Hessinger DA. The effect of Portuguese Man-of-war (Physalia physalis) venom on calcium, sodium and potassium fluxes of cultured embryonic chick heart cells. Toxicon 2000; 38:323-335.
13. Edwards L, Hessinger DA. Portuguese Man-of-war (Physalia physalis) venom induces calcium influx into cells by permeabilizing plasma membranes. Toxicon 2000; 38:1015-1028.
14. Pitt B. Diversity of calcium antagonists. Clin Ther 1997; 19 (Suppl A):3-17.
15. Alexander SPH, Mathjie A, Peters JA. In: Trends in Pharmacological Sciences Nomenclature Supplement 2001, 12th Ed. Elsevier Science, London 2001; 107-109.
16. Fleckenstein A. Calcium Antagonism in Heart and Smooth Muscle. John Wiley & Sons, New York 1983; 286-320.
17. Burnett JW, Othman IB, Endean R, Fenner PJ, Callanan VI, Williamson JA. Verapamil potentiation of Chironex (box-jellyfish) antivenom. Toxicon 1990; 28:242-244.
18. Currie B. Clinical implications of research on the box-jellyfish Chironex fleckeri. Toxicon 1994; 32:1305-1313.
19. Tibballs J, Williams D, Sutherland SK. The effects of antivenom and verapamil on the haemodynamic actions of Chironex fleckeri (box jellyfish) venom. Anaesth Intensive Care 1998; 26:40-45.
20. Hahn AW, Resink TJ, Kern F, Buhler FR. Peptide vasoconstrictions, vessel structure, and vascular smooth-muscle proliferation. J Cardiovasc Pharmac 1993; 22 (Suppl 5):S37-S43.
21. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JD, Limbird LE, Molinoff PB, Rudden RW, Gilman AG, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th Ed. McGraw-Hill, New York 1995; 199-248.
22. Sakanashi M, Miyamoto Y, Ito H, Takeo S, Noguchi K, Higa T. Possible α-adrenoceptor blocking activity of arotinolol (S-596), a new β-adrenoceptor blocking agent in isolated dog coronary artery. Pharmacology 1984; 29:204-209.